AstraZeneca to Pay $520M over Drug Marketing
Company Promoted Antipsychotic Drug Sroquel for "Off Label" Uses Not Approved by FDA
Attorney General Eric Holder says the federal government has reached a $520 million settlement with pharmaceutical manufacturer AstraZeneca, resolving allegations surrounding the company's antipsychotic drug Seroquel.
The case involves AstraZeneca promoting Seroquel for so-called "off-label" uses that are not approved by federal drug regulators, including insomnia and psychiatric conditions besides schizophrenia and bipolar disorder.
"As part of this scheme, AstraZeneca was accused of illegally promoting Seroquel to physicians and violating the federal Anti-Kickback statute, all in furtherance of supporting the drug's use for a host of illnesses for which it was never approved," Holder said in prepared remarks released Tuesday. "According to the settlement, AstraZeneca's illegal marketing of the drug led to millions of dollars in false claims against federal and state programs like Medicare and Medicaid."
The fine is the largest amount ever paid by a company in a civil settlement for off-label marketing, Holder said.
© 2010 CBS Interactive Inc. All Rights Reserved. This material may not be published, broadcast, rewritten, or redistributed. The Associated Press contributed to this report. Attorney General Eric Holder says the federal government has reached a $520 million settlement with pharmaceutical manufacturer AstraZeneca, resolving allegations surrounding the company's antipsychotic drug Seroquel.
The case involves AstraZeneca promoting Seroquel for so-called "off-label" uses that are not approved by federal drug regulators, including insomnia and psychiatric conditions besides schizophrenia and bipolar disorder.
"As part of this scheme, AstraZeneca was accused of illegally promoting Seroquel to physicians and violating the federal Anti-Kickback statute, all in furtherance of supporting the drug's use for a host of illnesses for which it was never approved," Holder said in prepared remarks released Tuesday. "According to the settlement, AstraZeneca's illegal marketing of the drug led to millions of dollars in false claims against federal and state programs like Medicare and Medicaid."
The fine is the largest amount ever paid by a company in a civil settlement for off-label marketing, Holder said.
Popular on MoneyWatch
- Reverse cell phone lookup service is free and simple
- Forbes names most powerful women 2013 10 Photos
- Student loan defaults rising despite a way out
- Rent the cake? Unusual tips to cut your wedding bill
- Amy's Baking Company could face legal 'nightmare'
- Top 10 professional life coaching myths
- How to stop the mediocrity pandemic
- How to organize your job hunt















(Please correct me if my facts are incorrect.)